Ferroptosis-centered Drug Response Information
General Information of the Drug (ID: ferrodrug0367)
Name |
Ringer's lactate
|
||||
---|---|---|---|---|---|
Synonyms |
Ringer's lactate; 8022-63-7; Ringer-lactate; Ringer's injection, lactated; Propanoic acid, 2-hydroxy-, monosodium salt, mixt. with calcium chloride (CaCl2), potassium chloride (KCl) and sodium chloride (NaCl)
Click to Show/Hide
|
||||
Structure |
![]() |
||||
3D MOL
|
|||||
Formula |
C3H6CaCl4KNa2O3
|
||||
Canonical SMILES |
CC(C(=O)O)O.[Na].[Na+].[Cl-].[Cl-].[Cl-].[Cl-].[K+].[Ca+2]
|
||||
InChI |
InChI=1S/C3H6O3.Ca.4ClH.K.2Na/c1-2(4)3(5)6;;;;;;;;/h2,4H,1H3,(H,5,6);;4*1H;;;/q;+2;;;;;+1;;+1/p-4
|
||||
InChIKey |
ZEWYCNBZMPELPF-UHFFFAOYSA-J
|
||||
PubChem CID |
Full List of Ferroptosis Target Related to This Drug
Unspecific Target
In total 1 item(s) under this Target | ||||
Experiment 1 Reporting the Ferroptosis-centered Drug Act on This Target | [1] | |||
Responsed Disease | Pleural mesothelioma | ICD-11: 2C26 | ||
Pathway Response | Ferroptosis | hsa04216 | ||
Autophagy | hsa04140 | |||
NF-kappa B signaling pathway | hsa04064 | |||
Cell Process | Cell ferroptosis | |||
Cell autophagy | ||||
In Vitro Model | Y-MESO-8A cells | Pleural mesothelioma | Homo sapiens | CVCL_5188 |
NCI-H290 cells | Pleural mesothelioma | Homo sapiens | CVCL_A555 | |
LP-9 cells | Normal | Homo sapiens | CVCL_E109 | |
HT-1080 cells | Fibrosarcoma | Homo sapiens | CVCL_0317 | |
Response regulation | Ringer's lactate (PAL) induces selective ferroptosis of malignant mesothelioma (MM) cells. PAL-induced ferroptosis accompanied autophagic process in the early phase, as demonstrated by an increase in essential amino acids, LC3B-II, p62 and LAMP1, transforming into the later phase with boosted lipid peroxidation. | |||